Menu Close

Trending

13th World Multispecifics Summit
4th Extracellular Vesicle-Based Therapeutic Development Summit
Mirati heads for FDA verdict on KRAS drug with new data
Roche trumpets new glofitamab data in lymphoma at ASCO
J&J, Legend get EU nod for myeloma CAR-T Carvykti

Insights

The-Value-of-Patient-Engagement-1200x675

Insights/ Patients/ White Papers/ Whitepapers

Incorporating the patient voice from clinical development to commercialisation

, , , , , 0 Comment

Patients increasingly want to be more involved in their healthcare, decisions about it and research towards its improvement,

X
Incorporating the patient voice from clinical development to commercialisation
https://pharmaphorum.com/patients/incorporating-the-patient-voice-from-clinical-development-to-commercialisation/
blockchain

Debates & Insight/ Debates & Insight/ Debates & Insights/ Digital/ Insights/ Insights/ Insights/ Patients/ R&D/ White Papers/ Whitepapers

Understanding blockchain – a practical guide for life sciences companies

, , , 0 Comment

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

X
Understanding blockchain – a practical guide for life sciences companies
https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/
hand image 1200x675

Debates & Insight/ Insights/ Patients/ White Papers/ Whitepapers

How pharma can boost engagement by embracing support networks

, , , , , , 0 Comment

Connecting with patients has become a central plank in the pharma marketing playbook, but should companies be looking

X
How pharma can boost engagement by embracing support networks
https://pharmaphorum.com/patients/insights-patients/how-pharma-can-boost-engagement-by-embracing-support-networks/
Stethescope heart

Debates & Insight/ Insights/ Patients/ Slider in whitepapers/ UK & Europe/ White Papers/ Whitepapers

Patient centricity: Identifying how Boehringer Ingelheim UK can be better

, , 0 Comment

Boehringer Ingelheim UK provides an update on its patient centricity initiative ahead of a new white paper later this year.

X
Patient centricity: Identifying how Boehringer Ingelheim UK can be better
https://pharmaphorum.com/debates-insight-patients/patient-centricity-identifying-boehringer-ingelheim-uk-can-better/
Whitepaper image

Insights/ Patients/ Sales and Marketing/ White Papers/ Whitepapers

From ideals to execution: the reality of patient-centricity in 2016 and what’s next for pharma

, , , 0 Comment

‘Patient-centricity’ is one of the buzzwords of the life sciences industry. It demonstrates a shift in the way

X
From ideals to execution: the reality of patient-centricity in 2016 and what’s next for pharma
https://pharmaphorum.com/whitepapers/ideals-execution-reality-patient-centricity-2016-whats-next-pharma/
digital_ecosystem_west

Healthcare/ Insights/ Insights/ Patients/ R&D/ White Papers/ Whitepapers

An integrated digital ecosystem to support patient outcomes, health-system sustainability, and return on investment

0 Comment

  Demand for improved pharmaceutical care that enhances the patient experience is ever increasing, and meanwhile outcomes-based medicine

X
An integrated digital ecosystem to support patient outcomes, health-system sustainability, and return on investment
https://pharmaphorum.com/whitepapers/an-integrated-digital-ecosystem-to-support-patient-outcomes-health-system-sustainability-and-return-on-investment/

Insights/ Patients/ Pharma Market Access/ White Papers/ Whitepapers

Patient centricity: What it means and why it’s important to have patients at the centre of our thinking

0 Comment

Having clear parameters of patient‑centricity that can be measured year-on-year enables Boehringer Ingelheim UK to know if it

X
Patient centricity: What it means and why it’s important to have patients at the centre of our thinking
https://pharmaphorum.com/whitepapers/patient-centricity-what-it-means-and-why-it-s-important-to-have-patients-at-the-centre-of-our-thinking/
1 2 3

Login

CONTINUE TO SITE >
X
Close in 10 seconds